Physician profile
Stacia E Souter
NPI 1972828515
$5,262.79
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,177 · 2022: $934 · 2023: $344 · 2024: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $2,681.97 | 2021 | |
| Boston Scientific Corporation | $2,064.20 | 2021-2024 | Wavewriter Alpha Prime 16, Patient Trial Kit, Freelink |
| Abbvie INC. | $78.87 | 2022-2024 | |
| Nevro Corp. | $72.44 | 2021-2023 | Senza |
| Curonix LLC | $62.18 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $62.15 | 2024 | Synchromedii, V-Loc 180 |
| Abbott Laboratories | $59.48 | 2022-2023 | Proclaim |
| Spr Therapeutics, INC | $56.00 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $28.86 | 2021 | |
| Depuy Synthes Sales INC. | $21.06 | 2022 | |
| Almatica Pharma LLC | $20.87 | 2021 | |
| Vertos Medical, INC. | $20.06 | 2024 | Mild Device Kit |
| Bioventus LLC | $19.39 | 2022 | |
| Amgen INC. | $15.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacia Souter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.